Nuveen Real Asset Income & Growth Fund (JRI) officer exercises 7,872 rights

Rhea-AI Filing Summary

Nuveen Real Asset Income & Growth Fund’s Chief Administrative Officer David J. Lamb exercised subscription rights to acquire 7,872 shares of common stock at an exercise price of $12.40 per share. These rights, classified as derivative securities, were fully exercised, leaving no remaining subscription rights outstanding after the transaction.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LAMB DAVID J

(Last) (First) (Middle)

C/O NUVEEN INVESTMENTS

333 W. WACKER DRIVE

(Street)

CHICAGO IL 60606

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Nuveen Real Asset Income & Growth Fund [ JRI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Administrative Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Subscription Right	$12.4	03/13/2026		X			7,872	02/06/2026	03/09/2026	Common Stock	7,872	$12.4	0.0000	D

Explanation of Responses:

Remarks:

lambpoa.txt

	Mark L. Winget/ Signed Under POA	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Nuveen Real Asset Income & Growth Fund (JRI) report?

Nuveen Real Asset Income & Growth Fund reported that Chief Administrative Officer David J. Lamb exercised subscription rights to acquire 7,872 shares of common stock at $12.40 per share. This Form 4 filing reflects an in-the-money derivative exercise, not an open-market stock purchase or sale.

Who is the insider in JRI’s latest Form 4 and what is their role?

The insider is David J. Lamb, who serves as Chief Administrative Officer of Nuveen Real Asset Income & Growth Fund. He reported exercising derivative subscription rights into common stock, illustrating a compensation or rights-related transaction rather than a discretionary market trade.

How many JRI shares were involved in David J. Lamb’s derivative exercise?

David J. Lamb exercised subscription rights covering 7,872 underlying shares of Nuveen Real Asset Income & Growth Fund common stock. The rights were exercised at $12.40 per share, converting derivative rights into an equivalent number of common shares in a single reported transaction.

Was David J. Lamb’s JRI transaction a stock purchase or sale in the market?

The transaction was not an open-market purchase or sale. Instead, David J. Lamb executed an in-the-money exercise of subscription rights, a type of derivative security, to acquire 7,872 common shares at a predetermined exercise price of $12.40 per share.

What happened to David J. Lamb’s JRI subscription rights after the exercise?

After the exercise, the reported balance of subscription rights was zero. The Form 4 shows that all 7,872 rights were converted into common stock, leaving no remaining subscription right derivatives outstanding for this specific grant following the transaction.

Does the JRI Form 4 indicate any remaining derivative positions for the insider?

The filing’s derivative summary is empty after this exercise, indicating no remaining derivative positions from the reported subscription rights. The only derivative transaction disclosed is the exercise of 7,872 rights into common stock at $12.40 per share.